
Vælg din etiket
vises direkte på hætteglasset7 laboratorierapporter
PDF- Testet
- Retatrutide 10mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (10.37 mg measured)
- Endotoksiner
- 5.54 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 15mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (16.53 mg measured)
- Endotoksiner
- 5.91 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 30mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (31.88 mg measured)
- Endotoksiner
- 6.29 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 40mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (40.92 mg measured)
- Endotoksiner
- 6.82 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 60mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (60.10 mg measured)
- Endotoksiner
- 7.73 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 20mg
- Laboratorium
- Analiza Białek
- Dato
- October 2026
- Resultat
- 99% purity (23.28 mg measured)
- Endotoksiner
- 6.15 EU/vial
- Ordrenr.
- Adgangskode
PDF- Testet
- Retatrutide 5mg
- Laboratorium
- Analiza Białek
- Dato
- July 2026
- Resultat
- 99% purity (5.28 mg measured)
- Ordrenr.
- Adgangskode
Uafhængigt testet, kan verificeres med adgangskoden direkte hos laboratoriet.
Retatrutide
GLP-1
- Laboratorietestet · 99% renhed
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
4.6 ud af 5 på Trustpilot73 anmeldelser
Søges også som: Retatrutid · Reta · LY3437943
Kort fortalt
Retatrutide i tal
Nøgletallene fra vores leksikon. Træk punktet langs kurven for at se, hvor meget der er tilbage efter én dosis, beregnet.
Hele leksikonopslagetHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~6 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
~6days
- Class
- Triple agonistGLP-1 / GIP / glucagon
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 60 mg11 sizes in the shop
What studies show
All 10 sources in the lexicon- up to25 %
Phase 3 trial TRIUMPH-1 in obesity (up to 25% weight reduction at 80 weeks) (opens in a new tab)
Jastreboff et al., New England Journal of Medicine, 2026 - up to18.8 %Bellido et al., The Lancet, 2026
- up to~24 %
Phase 2 study in obesity (up to ~24% weight reduction at 48 weeks) (opens in a new tab)
Jastreboff et al., New England Journal of Medicine, 2023
Anmeldelser
Hvad kunderne siger
Kun rigtige bestillinger, der indeholdt Retatrutide.
Alle anmeldelserViden
Alt om Retatrutide
Detaljerede oplysninger kommer snart.
Dosering
Indlæser doseringsinformation …
Godt at have
Det har du brug for til den
Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.
Insulinsprøjter
10 stk. · 5.50 €
Spritservietter
50 stk. · 10 €
Hvor meget vand?
Enheder på sprøjten til din hætteglasstørrelse.
Åbn beregneren →Is Retatrutide approved?
No, as of 25 October 2026 there is no approval. Retatrutide is in phase 3: 14 phase 3 trials are listed on ClinicalTrials.gov, five of them completed. The first phase 3 results were published in 2026.
How does Retatrutide differ from Tirzepatide and Semaglutide?
The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GLP-1 and GIP. Retatrutide also targets the glucagon receptor. In animal models this added higher energy expenditure. A head-to-head trial against Tirzepatide is still running (TRIUMPH-5).
What did the phase 3 trials show?
In TRIUMPH-1 (obesity without diabetes) weight fell by 25.0 percent on average after 80 weeks at the highest study dose, by 3.9 percent on placebo. In TRIUMPH-2 (with type 2 diabetes) it was 18.8 versus 5.1 percent. In TRANSCEND-T2D-1 long-term blood sugar (HbA1c) fell by up to 1.94 percentage points in 40 weeks.
What happens to liver fat?
In a substudy with fatty liver (MASLD) liver fat fell by about 81 to 82 percent after 24 weeks in the two higher levels. 86 percent reached normal liver fat below 5 percent at the highest level. A large phase 3 trial on liver disease runs until 2030.
Which side effects were seen?
Most often gastrointestinal effects such as nausea and diarrhoea, depending on the dose. In TRIUMPH-2 abnormal skin sensations (dysaesthesia) and low blood pressure occurred more often than on placebo. In the phase 2 trial heart rate rose in a dose-dependent way, most around week 24.
Which trials are still running?
Nine phase 3 trials are not finished yet. The largest: TRIUMPH-OUTCOMES on heart and kidney events with about 10,000 participants (planned end 2029) and SYNERGY-Outcomes on fatty liver (2030). The comparison with Tirzepatide (TRIUMPH-5) is due to reach its primary endpoint in November 2026.
Sammenligninger
Sådan klarer den sig
Relateret
Relaterede produkter
Tirzepatide
Peptider · GLP-1 & fedttab GLP-1 & fedttab
10 størrelser
Laboratorietestet
= fra 10 €/hætteglas
Semaglutide
Peptider · GLP-1 & fedttab GLP-1 & fedttab
6 størrelser
Laboratorietestet
= fra 10 €/hætteglas
Mazdutide
Peptider · GLP-1 & fedttab GLP-1 & fedttab
2 størrelser
= fra 32 €/hætteglas
Survodutide
Peptider · GLP-1 & fedttab GLP-1 & fedttab
1 størrelse
= 60.8 €/hætteglas
Retatrutide

